Potential impact of tuberculosis vaccines in China, South Africa, and IndiaFriday, August 9, 2024Availability, Epidemiological impactRead More
The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug resistant tuberculosis in India and ChinaFriday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
Making wider use of the world’s most widely used vaccine: Bacille Calmette-Guerin revaccination reconsideredFriday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
Epidemiological impact of targeted interventions for people with diabetes mellitus on tuberculosis transmission in India: Modelling based predictionsFriday, August 9, 2024Availability, Epidemiological impactRead More
New tuberculosis vaccines in India: Modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01E and BCG-revaccinationFriday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
Evaluating vaccination strategies for tuberculosis in endemic and non-endemic settingsFriday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
BCG and new preventive tuberculosis vaccines: Implications for healthcare workers.Friday, August 9, 2024Accessibility, Implementation strategies and feasibilityRead More
Mixed vaccination strategy for the control of tuberculosis: A case study in ChinaFriday, August 9, 2024Availability, Epidemiological impactRead More
ACEITar: Evaluation of the acceptability of new and repurposed tuberculosis vaccines in Mozambique Friday, August 9, 2024Acceptability, Acceptability and demandRead More
Is neglect of self-clearance biasing TB vaccine impact estimates?Friday, August 9, 2024Availability, Epidemiological impactRead More
